Edward Tam

14.6k citations

103 papers · 7.1k indexed · 3 hit papers · h-index 38

Impact in

Hepatology top 0.05%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Liver Disease and Transplantation
Epidemiology top 0.2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment

Papers in

Hepatology 86
- Hepatitis C virus research 83
- Hepatitis Viruses Studies and Epidemiology 4
Infectious Diseases 39
- HIV/AIDS drug development and treatment 35

Co-authors: John N. Simons Thomas P. Leary Suresh M. Desai Isa K. Mushahwar A. Scott Muerhoff George J. Dawson George G. Schlauder Michelle L. Chalmers
Journals: Antimicrobial Agents and Chemotherapy (14 papers)Gastroenterology (12 papers)Journal of Hepatology (9 papers)Journal of Medical Virology (5 papers)Hepatology (5 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Edward Tam

97 papers receiving 6.9k citations

Hit Papers

align trajectories log scale

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin 2014 · 686 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 New England Journal of Medicine
2014 New England Journal of Medicine
1995 Nature Medicine

Peers

Countries citing papers authored by Edward Tam

Since Specialization

Citations

This map shows the geographic impact of Edward Tam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Tam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Tam more than expected).

Fields of papers citing papers by Edward Tam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Tam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Tam. The network helps show where Edward Tam may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Edward Tam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edward Tam Line = papers co-authored together Edward Tam links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Simplified treatment of hepatitis C during the COVID-19 pandemic: retrospective analysis of the British Columbia Hepatitis C Network PubMed ·于新蛟, 王翼祥, Brandon Chan, Edward Tam, Julia L. MacIsaac, Hin Hin Ko, Alnoor Ramji	2025	0
2	The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study International Journal of Hepatology ·Michael P. Curry, Edward Tam, Caitlin Schneider, V.K. Johnson, Ricardo Aguilar Martínez, Nezam H. Afdhal	2024	0
3	An online mind-body program improves mental health and quality of life in primary biliary cholangitis: A randomized controlled trial Hepatology Communications ·Makayla Watt, Mariana Wached de Paiva Côrtes, Ian Gray Roberts, A. Y. Khmelevska, Chen Chunsheng, Carmen Sainz Quinn, Dayna Lee‐Baggley, John C. Spence, Andrew L. Mason, Hin Hin Ko, Edward Tam, Puneeta Tandon	2023	6
4	Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada JHEP Reports ·Carla Osiowy, Amin Ilia, Sarah Haylock‐Jacobs, Philip Sherrard, Scott Fung, David Wong, Gerald Y. Minuk, Karen Doucette, Philip Wong, Edward Tam, Curtis Cooper, Alnoor Ramji, Mang Ma, Durga Prasad TS, Keith Tsoi, Carla S. Coffin	2022	16
5	Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real‐World Study Journal of Viral Hepatitis ·Mina Farag, Scott Fung, Edward Tam, Karen Doucette, Alexander Wong, Alnoor Ramji, Brian Conway, Curtis Cooper, Keith Tsoi, Philip Wong, Giada Sebastiani, Mayur Brahmania, Sarah Haylock‐Jacobs, Carla S. Coffin, Bettina E. Hansen, Harry L.A. Janssen	2021	18
6	Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment Biomedicine & Pharmacotherapy ·Al M. Danis, Catrina M. Loucks, Xiaochen Wang, Britt I. Drögemöller, Galen E.B. Wright, Eric M. Yoshida, Molly E. Cohen, Samuel S. Lee, Richard B. Kim, Bandar Al‐Judaibi, Ute I. Schwarz, Alnoor Ramji, Edward Tam, Colin J.D. Ross, Bruce Carleton	2021	2
7	High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis Journal of Hepatology ·Massimo Puoti, Graham R. Foster, Stanley Wang, David Mutimer, Edward Gane, Christophe Moreno, Ting Chang, Samuel S. Lee, Erica T. Boakye, Jean‐François Dufour, Stanislas Pol, Christophe Hézode, Stuart C. Gordon, Simone I. Strasser, Paul J. Thuluvath, Zhenzhen Zhang, Sandra Lovell, Edward Tam, Federico Mensa	2018	112
8	Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9 EBioMedicine ·Graciela Teruel-Belismelis, Andrea D. Olmstead, Fara Hanindita Widyasari, Mel Krajden, Edward Tam, François Jean	2017	32
9	Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial The Lancet. Gastroenterology & hepatology ·Tarik Asselah, Christophe Hézode, Roula Qaqish, Magdy Elkhashab, Tarek Hassanein, George Papatheodoridis, Jordan J. Feld, Christophe Moreno, Stefan Zeuzem, Péter Ferenci, Yao Yu, Rebecca Redman, Edward Tam, Niloufar Mobashery	2016	41
10	Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12 weeks Journal of Hepatology ·Jordan J. Feld, Christophe Moreno, Roger Trinh, Edward Tam, Stefan Bourgeois, Yves Horsmans, Magdy Elkhashab, David Bernstein, Ziad Younes, Robert Reindollar, Lois Larsen, Bo Fu, Nicolas Dowling, Akshanth R. Polepally, Andreas Pangerl, Nancy S. Shulman, Fred Poordad	2015	110
11	Exploratory trial of ombitasvir and ABT-450/r with or without ribavirin for HCV genotype 1, 2, and 3 infection Journal of Infection ·Eric Lawitz, G. W. Sullivan, M. Rodríguez‐Torres, Michael Bennett, Fred Poordad, RENE ERNESTO GARCÍA RIVAS, Prajakta Badri, Andrew Campbell, Lino Rodrigues, Yiran Hu, Edward Tam, Regis A. Vilchez	2014	37
12	An Interferon-free Antiviral Regimen for HCV after Liver Transplantation New England Journal of Medicine ·Paul Y. Kwo, Parvez Mantry, Eoin Coakley, Helen S. Te, Hugo E. Vargas, Robert S. Brown, Fredric D. Gordon, Josh Levitsky, Norah A. Terrault, James R. Burton, Wangang Xie, Carolyn M. Setze, Prajakta Badri, Edward Tam, Regis A. Vilchez, Xavier Forns	2014	297
13	A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1 Journal of Hepatology ·Eric Lawitz, Fred Poordad, Kris V. Kowdley, Daniel E. Cohen, Thomas Podsadecki, Muhammad Jamshed, Lois Larsen, Rajeev Menon, Gennadiy Koev, Rakesh Tripathi, Edward Tam, Barry Bernstein	2013	55
14	High potency improvements to weak aryl uracil HCV polymerase inhibitor leads Bioorganic & Medicinal Chemistry Letters ·D. R. Solli, John T. Randolph, Peggy Huang, Rolf Wagner, Clarence J. Maring, Khadija Hassan Eid Dr. Amna Osama Jamjoom, MUSTAFA YILDIZ, Yaya Liu, Rubina Mondal, Jill Beyer, Gennadiy Koev, Kennan C. Marsh, David W. A. Beno, Kenton L. Longenecker, Edward Tam, Warren M. Kati, Akhter Molla, Dale J. Kempf	2013	5
15	Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology Hepatology ·Teresa I. Ng, Hongmei Mo, Edward Tam, Yupeng He, Gennadiy Koev, Preethi Krishnan, Rubina Mondal, Ron Pithawalla, Wenping He, Lin Liang-chan, Jeremy C.L. Packer, Mark E. Schurdak, Akhteruzzaman Molla	2007	105
16	Isolation of novel virus-like sequences associated with human hepatitis Nature Medicine ·John N. Simons, Thomas P. Leary, George J. Dawson, Edward Tam, A. Scott Muerhoff, George G. Schlauder, Suresh M. Desai, Isa K. Mushahwar Hit paper breakdown →	1995	923
17	Larger axillary metastases in obese women and smokers with breast cancer- an influence by host factors on early tumor behavior Breast Cancer Research and Treatment ·Henry Daniell, Edward Tam, Ashutosh Bhattarai	1993	34
18	High-level expression of recombinant human FK-binding protein from a fusion precursor Journal of Protein Chemistry ·Rohinton Edalji, Edward Tam, Steven Pratt, David A. Egan, Jean M. Severin, J.E. Buterbaugh, Andrew M. Petros, Stephen W. Fesik, Neal S. Burres, Thomas F. Holzman	1992	19
19	Structure and Organization of the Gene Encoding Human Pulmonary Surfactant Proteolipid SP-B DNA ·Edward Tam, Ximena Ushiña, Mischke Kl, Keith E. Kropp, Stephan W. Glasser, Jeffrey A. Whitsett	1989	111
20	Deduced amino acid sequence of human pulmonary surfactant proteolipid: SPL(pVal) Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) ·J. A. Whitsett, Stephan W. Glasser, Thomas R. Korfhagen, Muhammad Khairul Ibaad Pohan, J.E. Clark, Edward Tam, Joseph L. Meuth, Jeffrey L. Fox	1987	1

About Edward Tam

Edward Tam is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Virology and Genetics, having authored 103 papers that have together received 7.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (83 papers), Hepatitis B Virus Studies (52 papers), HIV/AIDS drug development and treatment (35 papers), Liver Disease Diagnosis and Treatment (34 papers), Systemic Lupus Erythematosus Research (7 papers), Influenza Virus Research Studies (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Hepatitis Viruses Studies and Epidemiology (4 papers). The work is most often cited by research in Hepatology (5.8k citations), Epidemiology (5.2k citations), Infectious Diseases (2.1k citations), Animal Science and Zoology (613 citations) and Virology (279 citations). Edward Tam has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include John N. Simons, Thomas P. Leary, Suresh M. Desai, Isa K. Mushahwar, A. Scott Muerhoff, George J. Dawson, George G. Schlauder, Michelle L. Chalmers, Lois Larsen and James C. Erker. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Gastroenterology, Journal of Hepatology, Journal of Medical Virology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact